China Recombinant Human Follitropin Market Report 2018-2022 Featuring Merck Serono (GONAL-f) & GeneScience Pharmaceuticals Co., Ltd. (Jinsaiheng)

Published: 11/01/2019
China Recombinant Human Follitropin Market Report 2018-2022 Featuring Merck Serono (GONAL-f) & GeneScience Pharmaceuticals Co., Ltd. (Jinsaiheng)
Source: WWW.PRNEWSWIRE.COM

DUBLIN, Jan. 11, 2019 /PRNewswire/ -- The "Investigation Report on China's Recombinant Human Follitropin Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering In China's end markets of ART and sex hormone drugs, macromolecular bioengineered drugs such as...

Read more
Related news
Comment
FACEBOOK